IRM2

IRM2, LLC is a specialized legal entity and research subsidiary of Novartis, primarily serving as the operational vehicle for the Genomics Institute of the Novartis Research Foundation (GNF). Based in San Diego, the company focuses on bridging the gap between basic biomedical research and drug discovery through large-scale, technology-driven platforms. IRM2 utilizes advanced high-throughput screening, functional genomics, and automated proteomics to identify novel therapeutic targets and develop early-stage drug candidates. Its work spans a wide range of therapeutic areas, including oncology, regenerative medicine, and metabolic diseases, often feeding directly into the broader Novartis global pipeline. The entity is notable for its extensive patent portfolio and its role in developing foundational technologies for modern drug discovery.